Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
GenSight Biologics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

€0.3

2024-10-29

Market Capitalization

€34.5 M

2024-10-29

Revenue

€1 K

FY, 2025

CreditSafe Score

?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

EURFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue700.0K4.4M5.3M2.6M1.3M1.5M1.0K
Gross profit4.3M4.9M7.7M7.7M4.9M3.0M2.6M652.0K
Gross profit margin, %701.4%175.6%146.1%188.4%233.9%175.0%65200.0%
Operating expense total37.1M34.2M31.7M34.7M31.6M29.6M17.3M11.2M
Depreciation and amortization315.0K985.0K926.0K1.1M1.1M3.0M1.2M489.0K
EBITDA(32.7M)(29.3M)(24.0M)(27.0M)(26.7M)(26.7M)(14.6M)(10.6M)
EBITDA margin, %-4187.6%-546.4%-511.9%-1034.1%-2104.3%-975.5%-1056800.0%
EBIT(33.0M)(30.3M)(24.9M)(28.1M)(27.8M)(29.7M)(15.8M)(11.1M)
EBIT margin, %-4328.3%-567.5%-533.1%-1078.1%-2343.7%-1054.2%-1105700.0%
Interest income4.0K
Interest expense412.0K408.0K1.7M2.2M3.0M3.2M2.5M4.6M
Pre tax profit(33.5M)(30.9M)(34.0M)(28.6M)(27.6M)(26.2M)(14.0M)(12.0M)
Income tax expense4.0K2.0K2.0K5.0K21.0K(5.0K)
Net Income(33.5M)(30.9M)(34.0M)(28.6M)(27.6M)(26.2M)(14.0M)(12.0M)

Footer menu